Cited by 74Schizophrenia research and treatmentNeural dynamics and brain functionNeuroscience and Music Perception

Mismatch negativity (MMN) as a tool for translational investigations into early psychosis: A review

Open access
Tada, Mariko, Kirihara, Kenji, Mizutani, Shunsuke, Uka, Takanori, Kunii, Naoto, Koshiyama, Daisuke, Fujioka, Mao, Usui, Kaori +3 more·2019·International Journal of Psychophysiology

Abstract

Mismatch negativity (MMN) reduction is one of the most robust findings among several neurophysiological and neurocognitive measures in patients with schizophrenia. MMN is a promising biomarker for schizophrenia because of the following properties: 1) its relationship with early psychosis, including clinical high-risk (CHR); 2) its relationship with the functional abilities of patients; and 3) its translatability into basic research using animal models. Specifically, the utility of the passive auditory oddball paradigm that does not require subjects to make behavioral responses enables identical physiological activities to be obtained from both experimental animals and patients. This advantage has contributed to clarifying the generating mechanism of MMN in various animal studies. We reviewed clinical reports focused on early psychosis; specifically differential effects of deviance type and relationships to clinical and functional outcome. For the utility of MMN as a tool for translational research, we next reviewed recent MMN studies in rodents and nonhuman primates (NHP) as well as studies using intracranial recordings in humans, a rare opportunity to detect neural signals in vivo in humans. Neural computations of MMN, such as adaptation, deviance detection, and predictive coding, have been recent topics for understanding MMN generating mechanisms. Finally, several significant research questions were provided for future directions. MMN research could contribute to innovative, novel, therapeutic strategies in the future by becoming a bridge between basic and clinical research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijpsycho.2019.02.009

Cites

123 of 123 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Recent studies have explained reduced MMN as altered predictive coding in schizophrenia.

    “Based on these findings, recent studies have explained reduced MMN as altered predictive coding in schizophrenia (12, 24).”

    From A Predictive Coding Perspective on Mismatch Negativity Impairment in Schizophrenia (2020) · cites this paper as [24]

    Section 4 describes predictive coding as a proposed mechanism for MMN and says recent studies suggest altered predictive coding may be related to schizophrenia. It also says MMN’s underlying neural computation remains under debate, so the review does not establish altered predictive coding as the explanation for reduced MMN. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • MMN can serve as a translational biomarker.

    “Because MMN can serve as a translational biomarker (24), animal studies measuring MMN can be used to investigate neurobiological mechanisms underlying altered predictive coding in schizophrenia.”
  • MMN is considered a translatable biomarker because paradigms for the measurement of MMN can be applied to non-human animals.

    “MMN is considered a translatable biomarker because paradigms for the measurement of MMN can be applied to non-human animals (24).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Gross, G., Huber, G., Klosterkftter, J., Linz, M., 1987. Bonner Skala fqr die Beurteilung von Basissymptomen (BSABS; Bonn Scale for the Assessment of Basic Symptoms). Springer, Berlin.
  2. Hamilton, H.K., Perez, V.B., Ford, J.M., Roach, B.J., Jaeger, J., Mathalon, D.H., 2018. Schizophr. Bull. 44 (3), 492-504.
  3. Hsieh, M.H., Shan, J.C., Huang, W.L., Cheng, W.C., Chiu, M.J., Jaw, F.S., Hwu, H.G., Liu, C.C., 2012. Schizophr. Res. 140 (1-3), 243-249.
  4. Swerdlow, N.R., Bhakta, S., Chou, H.H., Talledo, J.A., Balvaneda, B., Light, G.A., 2016. Neuropsychopharmacology 41 (2), 419-430.

Cited by

Sorted by citations

Authors
Tada, M., Kirihara, K., Mizutani, S., Uka, T., Kunii, N., Koshiyama, D., Fujioka, M., Usui, K., Nagai, T., Araki, T., & Kasai, K.
Affiliations
  • International Research Center for Neurointelligence, The University of Tokyo (JP)
  • The University of Tokyo (JP)
  • University of Yamanashi (JP)
  • University of Tokyo Hospital (JP)
Corresponding author
Kasai, Kiyoto
Venue
International Journal of Psychophysiology
Publisher
Elsevier BV
Published
2019-11
Volume
145
Pages
5-14
ISSN
0167-8760 (ISSN-L)
OpenAlex
W2919708535
Cited by
74
References
123
Citations by year
2026: 5 · 2025: 9 · 2024: 10 · 2023: 11 · 2022: 9 · 2021: 15 · 2020: 13 · 2019: 2
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • International Journal of Psychophysiology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • Japan Society for the Promotion of Science (15H06166, 18K07588)
  • Japan Agency for Medical Research and Development (JP17dm0207004)
  • University of Tokyo Institutes for Advanced Study
  • University of Tokyo Center for Integrative Science of Human Behavior
  • SENSHIN Medical Research Foundation
  • Takeda Science Foundation
  • Naito Foundation
  • Kurata Grants
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural dynamics and brain function
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neuroscience and Music Perception
Keywords
mismatch negativity, early psychosis, schizophrenia, deviance detection, predictive coding, neural adaptation, biomarkers, animal models of schizophrenia, non-human primates, rodent models, intracranial recordings, functional outcome
MeSH terms
Animals, Auditory Cortex, Auditory Perception, Disease Models, Animal, Electroencephalography, Evoked Potentials, Auditory, Humans, Psychotic Disorders, Schizophrenia, Translational Research, Biomedical

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review